Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agomelatine for Delirium
IRCT20250411065288N1Phase 3Recruiting
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of agomelatine in delirium, sponsored by Shahid Beheshti University of Medical Sciences. Started Jun 2025; status: recruiting.
02
Drugs
agomelatine
03
Conditions
delirium
Beyond the preview
Go deeper on IRCT20250411065288N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250411065288N1.